Kian Shaker,1 Giovanni Marco Saladino,1 Carmen Vogt,1 Yurika Katsu-Jimenéz,2 Bertha Brodin,1 Raoul V. Kuiper,2 Kenth Andersson,1 Yuyang Li,1 Jakob C. Larsson,1 Martin Svenda,1 Aida Rodriguez-Garcia,2 Muhammet S. Toprakhttps://orcid.org/0000-0001-5678-5298,1 Marie Arsenian-Henriksson,2 Hans M. Hertz1
1KTH Royal Institute of Technology (Sweden) 2Karolinska Institute (Sweden)
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
Laboratory x-ray fluorescence (XRF) computed tomography (XFCT) with nanoparticles (NPs) as contrast agents now allows for in vivo preclinical imaging and longitudinal studies at low radiation dose. We present on developments of our XFCT arrangement capable of low-dose (<25 mGy) imaging with high signal-to-background resulting in high-spatial-resolution (200-400 μm) in vivo imaging of Ru, Rh and Mo NPs injected and accumulated locally in mice. We further demonstrate multiplexing capabilities by cross-talk-free separation of Ru, Rh and Mo XRF signal as well as envisioning the future of preclinical XFCT for active targeting and imaging of molecular markers (e.g., cancer cells).
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
The alert did not successfully save. Please try again later.
Kian Shaker, Giovanni Marco Saladino, Carmen Vogt, Yurika Katsu-Jimenéz, Bertha Brodin, Raoul V. Kuiper, Kenth Andersson, Yuyang Li, Jakob C. Larsson, Martin Svenda, Aida Rodriguez-Garcia, Muhammet S. Toprak, Marie Arsenian-Henriksson, Hans M. Hertz, "Laboratory x-ray fluorescence computed tomography for in vivo preclinical imaging," Proc. SPIE 11840, Developments in X-Ray Tomography XIII, 118400Y (1 August 2021); https://doi.org/10.1117/12.2595614